Board of Directors

Joseph Papa joined the Milestone Pharmaceuticals Board of Directors in September 2024. Mr. Papa is an experienced healthcare leader who has spent his career championing products that improve patients’ lives and empowering the teams responsible for bringing those products to market. He has a track record of driving growth and navigating companies through periods of transformation.

Joseph Papa has over 35 years of experience in the pharmaceutical, healthcare and specialty pharmaceutical industries. Since February 2024, he has served as Chief Executive Officer of Emergent BioSolutions (NYSE: EBS). Previously, Mr. Papa served as Chairman and CEO of Bausch Health (NYSE: BHC) from 2016 to 2022, where he oversaw the company’s rapid growth and spin-off of Bausch + Lomb (NYSE: BLCO). He served as Chief Executive Officer of Bausch + Lomb Corporation from May 2022 to March 2023 to facilitate a smooth leadership transition. From 2006 to 2016, Mr. Papa served as Chairman and CEO of Perrigo (NYSE: PRGO). Prior to Perrigo, Mr. Papa served as President of PTS for Cardinal Health (NYSE: CAH), President of Watson Pharmaceuticals, President of U.S. operations for Searle/Pharmacia, Chief Operating Officer of DuPont Pharmaceuticals (NYSE: DD) and Vice President of Marketing for Novartis (NYSE: NVS). He currently serves as Chair of the board of directors of SparingVision, a privately held genomic medicines company, and as a member of the board of directors of Candel Therapeutics (Nasdaq: CADL), a clinical stage biopharmaceutical company developing immunotherapies for cancer patients, where he chairs the compensation committee. He previously served on the boards of directors of Prometheus Biosciences (Nasdaq: RXDX) as lead independent director and chair of the compensation committee until the company’s sale to Merck (NYSE: MRK) in 2023 and Smith & Nephew plc (NYSE: SNN) as chair of the remuneration committee. Mr. Papa holds a B.S. in pharmacy from the University of Connecticut and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.